LivaNova PLC (NASDAQ:LIVN) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On January 26, Brett Fishbin from KeyBanc Capital Markets revised his rating on LivaNova PLC (NASDAQ:LIVN), from Sector Weight to Overweight. The analyst estimated a target price of $81 for the stock, yielding an upside of almost 27%. Esperion Therapeutics (ESPR) Gets Boost from Acquisition Rumors Copyright: lightwise / 123RF Stock Photo Fishbin’s rating upgrade is part of KeyBanc’s 2026 outlo ...